6bgb
From Proteopedia
(Difference between revisions)
												
			
			| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
==Crystal Structure of the 16mer GCAGNCUUAAGUCUGC containing BrPh 7-triazolyl-8-aza-7-deazaadenosine==  | ==Crystal Structure of the 16mer GCAGNCUUAAGUCUGC containing BrPh 7-triazolyl-8-aza-7-deazaadenosine==  | ||
| - | <StructureSection load='6bgb' size='340' side='right' caption='[[6bgb]], [[Resolution|resolution]] 1.65Å' scene=''>  | + | <StructureSection load='6bgb' size='340' side='right'caption='[[6bgb]], [[Resolution|resolution]] 1.65Å' scene=''>  | 
== Structural highlights ==  | == Structural highlights ==  | ||
| - | <table><tr><td colspan='2'>[[6bgb]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6BGB OCA]. For a <b>guided tour on the structure components</b> use [  | + | <table><tr><td colspan='2'>[[6bgb]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6BGB OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6BGB FirstGlance]. <br>  | 
| - | </td></tr><tr id='  | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.65Å</td></tr>  | 
| - | <tr id='  | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A7C:3-[1-(4-bromophenyl)-1H-1,2,3-triazol-4-yl]-1-[5-O-(trihydroxy-lambda~5~-phosphanyl)-beta-D-ribofuranosyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine'>A7C</scene></td></tr>  | 
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[  | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6bgb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6bgb OCA], [https://pdbe.org/6bgb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6bgb RCSB], [https://www.ebi.ac.uk/pdbsum/6bgb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6bgb ProSAT]</span></td></tr>  | 
</table>  | </table>  | ||
| - | <div style="background-color:#fffaf0;">  | ||
| - | == Publication Abstract from PubMed ==  | ||
| - | SiRNAs can cause unintended gene silencing due to miRNA-like effects because of the similarity in function of an siRNA guide strand and a miRNA. Here we evaluate the effect on miRNA-like off targeting of introducing the adenosine derivative 7-EAA and triazoles prepared from 7-EAA at different positions in an siRNA guide strand. We find that a sterically demanding triazole placed in the RNA duplex major groove at position six of the guide strand dramatically reduces miRNA-like off targeting potency. A high-resolution structure of an RNA duplex bearing a novel, major-groove localized triazole is reported, which suggests that modified triazoles could be disrupting the hAgo2-guide-target RNA ternary complex. Five different triazole modifications were tested at the guide strand 6-position for effects on on-target and miRNA-like off target knockdown potency. A 7-EAA triazole bearing a benzylamine substituent displayed on-target knockdown activity as potent as the native siRNA, while having an IC50 against a miRNA-like off target >100-fold higher. Melting temperature studies revealed no obvious correlation between potency in knockdown assays and a modification's effect on duplex stability. These results, along with known structures of hAgo2-guide-target ternary complexes, are used to rationalize the effect of 7-EAA triazoles on miRNA-like off target effects.  | ||
| - | |||
| - | Controlling miRNA-like off-target effects of an siRNA with nucleobase modifications.,Suter SR, Ball-Jones A, Mumbleau MM, Valenzuela R, Ibarra-Soza J, Owens H, Fisher AJ, Beal PA Org Biomol Chem. 2017 Nov 22. doi: 10.1039/c7ob02654d. PMID:29164215<ref>PMID:29164215</ref>  | ||
| - | |||
| - | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>  | ||
| - | </div>  | ||
| - | <div class="pdbe-citations 6bgb" style="background-color:#fffaf0;"></div>  | ||
| - | == References ==  | ||
| - | <references/>  | ||
__TOC__  | __TOC__  | ||
</StructureSection>  | </StructureSection>  | ||
| - | [[Category:   | + | [[Category: Large Structures]]  | 
| - | [[Category:   | + | [[Category: Synthetic construct]]  | 
| - | [[Category:   | + | [[Category: Beal PA]]  | 
| - | [[Category:   | + | [[Category: Fisher AJ]]  | 
| - | [[Category:   | + | [[Category: Mumbleau MM]]  | 
| - | + | ||
| - | + | ||
Current revision
Crystal Structure of the 16mer GCAGNCUUAAGUCUGC containing BrPh 7-triazolyl-8-aza-7-deazaadenosine
  | |||||||||||
